The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer

Yaheng Li1, Chuanyin Li1, Shuyuan Liu1

  • 1Department of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, Yunnan, China.

Insights

Single nucleotide polymorphisms (SNPs) in microRNA (miRNA) genes are linked to cervical cancer development. This review explores miRNA SNPs

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Cervical cancer is a major global health concern, ranking as the fourth most common gynecological malignancy and cause of cancer death in women.
  • MicroRNAs (miRNAs) are crucial noncoding RNA molecules regulating gene expression posttranscriptionally and are implicated in cervical cancer pathogenesis.
  • Single nucleotide polymorphisms (SNPs) within miRNA genes can affect miRNA function and are associated with various cancers, including cervical cancer.

Purpose of the Study:

  • To review the current research on the role of single nucleotide polymorphisms (SNPs) in microRNA (miRNA) genes in the development of cervical cancer.
  • To summarize the progress in understanding miRNA SNPs in cervical cancer.
  • To elucidate the molecular mechanisms underlying the regulation of miRNA SNPs in cervical cancer.

Main Methods:

  • Literature review of studies investigating miRNA SNPs and cervical cancer.
  • Analysis of research on the functional impact of miRNA SNPs on miRNA biogenesis and activity.
  • Synthesis of data on the association between specific miRNA SNPs and cervical cancer risk and progression.

Main Results:

  • Identified specific miRNA SNPs associated with altered miRNA expression and maturation.
  • Summarized evidence linking certain miRNA SNPs to increased susceptibility or progression of cervical cancer.
  • Highlighted the molecular pathways through which miRNA SNPs may influence cervical cancer development.

Conclusions:

  • miRNA SNPs represent a significant genetic factor influencing cervical cancer development.
  • Further research into miRNA SNPs could reveal novel biomarkers and therapeutic targets for cervical cancer.
  • Understanding the molecular mechanisms of miRNA SNPs is crucial for advancing cervical cancer prevention and treatment strategies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.2K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.2K